We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 6,801

Merger Control in the European Union
  • Baker McKenzie
  • European Union, Global
  • May 25 2018

A structured guide to merger control laws and practice in the European Union


Costco pharmacy directors fined for professional misconduct
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • May 23 2018

On March 14 2018 the discipline committee of the Ontario College of Pharmacists found that two directors of Costco pharmacies had committed acts of


Derailing the Gravy Train - Trump Unveils Plan to Reduce Drug Prices
  • Akerman LLP
  • USA
  • May 21 2018

Throughout his presidential campaign, President Trump championed the need to allow the government to negotiate drug prices on behalf of the Medicare


Drug Using Employee? Better Conduct An “Individualized Assessment” Before You Fire!
  • FisherBroyles LLP
  • USA
  • May 17 2018

It seems that a child development center in South Carolina just settled an EEOC disability lawsuit for $5,000 (and other remedies) for hiring someone


FDA Publishes List of Drug Companies Accused of Hindering Generic Entry: Antitrust Implications
  • Wilmer Cutler Pickering Hale and Dorr LLP
  • USA
  • May 17 2018

Today, as part of the Trump Administration's stated goal to lower drug prices, the Food and Drug Administration (FDA) published a list of


ITC Institutes Investigation Based on Allegation of Drug Sales Without FDA Approval
  • Jones Day
  • USA
  • May 17 2018

Normally, it is the FDA that monitors the improper distribution of drugs. But, as it turns out, the International Trade Commission ("ITC") might be


Administration Releases Blueprint to Lower Drug Prices, Reduce Out-of-Pocket Costs
  • Holland & Knight LLP
  • USA
  • May 15 2018

"American Patients First: The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs" outlines actions that the


President Trump Delivers Much Anticipated Drug Pricing Speech
  • Mintz Levin
  • USA
  • May 14 2018

On Friday, after weeks of delay, the President finally delivered his Drug Pricing Speech and released the HHS Blueprint detailing the Trump


Capitol Hill Healthcare Update
  • Baker & Hostetler LLP
  • USA
  • May 14 2018

On Capitol Hill, reaction to President Donald Trump’s “American Patients First” plan to bring down prescription drug prices fell predictably along


Administration Releases Long-Awaited Drug Pricing Reform Plan
  • Cooley LLP
  • USA
  • May 11 2018

Today, the President and Health and Human Services (HHS) Secretary Alex Azar unveiled a 44-page Blueprint to Lower Drug Prices and Reduce